Literature DB >> 19567450

Visually scoring hirsutism.

Bulent O Yildiz1, Sheila Bolour, Keslie Woods, April Moore, Ricardo Azziz.   

Abstract

BACKGROUND: Hirsutism is the presence of excess body or facial terminal (coarse) hair growth in females in a male-like pattern, affects 5-15% of women, and is an important sign of underlying androgen excess. Different methods are available for the assessment of hair growth in women.
METHODS: We conducted a literature search and analyzed the published studies that reported methods for the assessment of hair growth. We review the basic physiology of hair growth, the development of methods for visually quantifying hair growth, the comparison of these methods with objective measurements of hair growth, how hirsutism may be defined using a visual scoring method, the influence of race and ethnicity on hirsutism, and the impact of hirsutism in diagnosing androgen excess and polycystic ovary syndrome.
RESULTS: Objective methods for the assessment of hair growth including photographic evaluations and microscopic measurements are available but these techniques have limitations for clinical use, including a significant degree of complexity and a high cost. Alternatively, methods for visually scoring or quantifying the amount of terminal body and facial hair growth have been in use since the early 1920s; these methods are semi-quantitative at best and subject to significant inter-observer variability. The most common visual method of scoring the extent of body and facial terminal hair growth in use today is based on a modification of the method originally described by Ferriman and Gallwey in 1961 (i.e. the mFG method).
CONCLUSION: Overall, the mFG scoring method is a useful visual instrument for assessing excess terminal hair growth, and the presence of hirsutism, in women.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19567450      PMCID: PMC2792145          DOI: 10.1093/humupd/dmp024

Source DB:  PubMed          Journal:  Hum Reprod Update        ISSN: 1355-4786            Impact factor:   15.610


  75 in total

1.  Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline.

Authors:  Ricardo Azziz; Enrico Carmina; Didier Dewailly; Evanthia Diamanti-Kandarakis; Hector F Escobar-Morreale; Walter Futterweit; Onno E Janssen; Richard S Legro; Robert J Norman; Ann E Taylor; Selma F Witchel
Journal:  J Clin Endocrinol Metab       Date:  2006-08-29       Impact factor: 5.958

Review 2.  Polycystic ovary syndrome.

Authors:  David A Ehrmann
Journal:  N Engl J Med       Date:  2005-03-24       Impact factor: 91.245

3.  Randomized, double-blind clinical evaluation of the efficacy and safety of topical eflornithine HCl 13.9% cream in the treatment of women with facial hair.

Authors:  John E Wolf; Douglas Shander; Ferdinand Huber; Joseph Jackson; Chen-Sheng Lin; Barbara M Mathes; Kathy Schrode
Journal:  Int J Dermatol       Date:  2007-01       Impact factor: 2.736

Review 4.  The evaluation and treatment of androgen excess.

Authors: 
Journal:  Fertil Steril       Date:  2006-11       Impact factor: 7.329

5.  Health-related quality of life in women with polycystic ovary syndrome, a self-administered questionnaire, was validated.

Authors:  Gordon Guyatt; Bruce Weaver; Lisa Cronin; Julie Ann Dooley; Ricardo Azziz
Journal:  J Clin Epidemiol       Date:  2004-12       Impact factor: 6.437

6.  Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups.

Authors:  Wendy Y Chang; Eric S Knochenhauer; Alfred A Bartolucci; Ricardo Azziz
Journal:  Fertil Steril       Date:  2005-06       Impact factor: 7.329

7.  Ferriman Gallwey self-scoring I: performance assessment in women with polycystic ovary syndrome.

Authors:  Robert A Wild; Sara Vesely; Laura Beebe; Thomas Whitsett; Willis Owen
Journal:  J Clin Endocrinol Metab       Date:  2005-04-12       Impact factor: 5.958

8.  Degree of facial and body terminal hair growth in unselected black and white women: toward a populational definition of hirsutism.

Authors:  Catherine Marin DeUgarte; K S Woods; Alfred A Bartolucci; Ricardo Azziz
Journal:  J Clin Endocrinol Metab       Date:  2006-01-31       Impact factor: 5.958

9.  Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism.

Authors:  E Carmina; F Rosato; A Jannì; M Rizzo; R A Longo
Journal:  J Clin Endocrinol Metab       Date:  2005-11-01       Impact factor: 5.958

10.  Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement.

Authors:  William Rosner; Richard J Auchus; Ricardo Azziz; Patrick M Sluss; Hershel Raff
Journal:  J Clin Endocrinol Metab       Date:  2006-11-07       Impact factor: 5.958

View more
  55 in total

1.  Interventional studies for polycystic ovarian syndrome in children and adolescents.

Authors:  Patricia Myriam Vuguin
Journal:  Ped Health       Date:  2010-02

Review 2.  New perspectives on the definition and management of polycystic ovary syndrome.

Authors:  R Pasquali; A Gambineri
Journal:  J Endocrinol Invest       Date:  2018-01-23       Impact factor: 4.256

3.  Reanalyzing the modified Ferriman-Gallwey score: is there a simpler method for assessing the extent of hirsutism?

Authors:  Heather Cook; Kathleen Brennan; Ricardo Azziz
Journal:  Fertil Steril       Date:  2011-09-15       Impact factor: 7.329

4.  Metabolic syndrome and the risk of cardiovascular complications in young patients with different phenotypes of polycystic ovary syndrome.

Authors:  Anna Krentowska; Agnieszka Łebkowska; Małgorzata Jacewicz-Święcka; Justyna Hryniewicka; Monika Leśniewska; Agnieszka Adamska; Irina Kowalska
Journal:  Endocrine       Date:  2021-01-13       Impact factor: 3.633

5.  Evaluation of Topical Capislow Extract and Long Pulsed Nd-YAG Laser in the Treatment of Idiopathic Hirsutism.

Authors:  Hisham Shokeir; Nevien Samy; Hend Mahmoud; Mohamed L Elsaie
Journal:  J Lasers Med Sci       Date:  2018-03-20

Review 6.  Polycystic ovary syndrome: etiology, pathogenesis and diagnosis.

Authors:  Mark O Goodarzi; Daniel A Dumesic; Gregorio Chazenbalk; Ricardo Azziz
Journal:  Nat Rev Endocrinol       Date:  2011-01-25       Impact factor: 43.330

Review 7.  Diagnosis and challenges of polycystic ovary syndrome in adolescence.

Authors:  Sophia E Agapova; Tamara Cameo; Aviva B Sopher; Sharon E Oberfield
Journal:  Semin Reprod Med       Date:  2014-04-08       Impact factor: 1.303

8.  Impact of right-left differences in ovarian morphology on the ultrasound diagnosis of polycystic ovary syndrome.

Authors:  Brittany Y Jarrett; Heidi Vanden Brink; Eric D Brooks; Kathleen M Hoeger; Steven D Spandorfer; Roger A Pierson; Donna R Chizen; Marla E Lujan
Journal:  Fertil Steril       Date:  2019-08-05       Impact factor: 7.329

9.  The severity of menstrual dysfunction as a predictor of insulin resistance in PCOS.

Authors:  Meredith Brower; Kathleen Brennan; Marita Pall; Ricardo Azziz
Journal:  J Clin Endocrinol Metab       Date:  2013-10-03       Impact factor: 5.958

10.  Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome.

Authors:  Uche Ezeh; Bulent O Yildiz; Ricardo Azziz
Journal:  J Clin Endocrinol Metab       Date:  2013-03-28       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.